-

12:13:25 PM

Latest MSON Stock Market News

MSON - Misonix Inc

05/14/21 8:30 AM

Nasdaq : MSON

Misonix Appoints Patrick J. Beyer to Board of Directors

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical

RHEA-AI

very positive

05/10/21 1:30 PM

Nasdaq : MSON

Misonix to Participate in Upcoming May and June Virtual Investor Conferences

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Chief Executive Officer, Stavros Vizirgianakis, along with Chief

RHEA-AI

neutral

05/06/21 4:01 PM

Nasdaq : MSON

Misonix Reports Fiscal 2021 Third Quarter Financial Results

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and

RHEA-AI

neutral

04/20/21 8:15 AM

Nasdaq : MSON

Misonix to Report Fiscal 2021 Third Quarter Financial Results and Host Conference Call and Webcast on May 6

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 third quarter financial results

RHEA-AI

neutral

03/30/21 8:05 AM

Nasdaq : MSON

Misonix Expands Ultrasonic Technology Capabilities to Address the Orthoplastics Market

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the

RHEA-AI

positive

03/04/21 9:25 AM

Nasdaq : MSON

Misonix Receives Health Canada Approval for neXus

Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it has received a Health Canada

RHEA-AI

very positive

03/01/21 8:07 AM

Nasdaq : MSON

Misonix to Participate in Upcoming March Investor Conferences

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that it will be participating in the upcoming Cowen 41 st Annual

RHEA-AI

neutral

02/11/21 10:00 AM

Nasdaq : MSON

Misonix to Participate at Upcoming Investor Conferences

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Misonix Chief Executive Officer, Stavros Vizirgianakis, along

RHEA-AI

neutral

02/04/21 4:01 PM

Nasdaq : MSON

Misonix Reports Fiscal 2021 Second Quarter Financial Results

Misonix, Inc. (Nasdaq: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported financial results for the fiscal 2021

RHEA-AI

neutral

01/21/21 10:30 AM

Nasdaq : MSON

Misonix to Report Fiscal 2021 Second Quarter Financial Results and Host Conference Call and Webcast on February 4

Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, announced today that it will report its fiscal 2021 second quarter financial results

RHEA-AI

neutral

MSON Data

industry
websitewww.misonix.com
ceo
security nameMisonix Inc
issue typecs
sector
sic code
employees
tagsHealth Technology,Medical Specialties
address
address2
state
city
zip
country
phone

MSON Description:

Misonix, Inc. is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company's history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients.